Stay updated on Nivolumab in Refractory Biliary Tract Cancers Clinical Trial

Sign up to get notified when there's something new on the Nivolumab in Refractory Biliary Tract Cancers Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nivolumab in Refractory Biliary Tract Cancers Clinical Trial page

  1. Check
    6 days ago
    Change Detected
    Summary
    Footer revision updated: added Revision: v3.4.2 and removed Revision: v3.4.1.
    Difference
    0.1%
    Check dated 2026-02-12T02:45:54.000Z thumbnail image
  2. Check
    13 days ago
    Change Detected
    Summary
    Revision tag updated from v3.4.0 to v3.4.1 on the page. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-02-05T00:52:07.000Z thumbnail image
  3. Check
    20 days ago
    Change Detected
    Summary
    Added a 'Show glossary' toggle and updated the page revision header (Revision: v3.4.0), with minor capitalization tweaks to QC-related labels and FEAR Act wording.
    Difference
    0.2%
    Check dated 2026-01-28T21:13:08.000Z thumbnail image
  4. Check
    35 days ago
    Change Detected
    Summary
    Revision: v3.3.4 was added and Revision: v3.3.3 was removed.
    Difference
    0.1%
    Check dated 2026-01-14T04:11:25.000Z thumbnail image
  5. Check
    56 days ago
    Change Detected
    Summary
    Added study locations in California, Florida, and Georgia. Updated page to revision v3.3.3 on 2025-12-22.
    Difference
    0.7%
    Check dated 2025-12-23T22:32:10.000Z thumbnail image
  6. Check
    84 days ago
    Change Detected
    Summary
    These changes update the Publications section to say publications are automatically filled from PubMed, and update the page revision to v3.3.2. They do not affect the study data, eligibility criteria, or locations.
    Difference
    0.1%
    Check dated 2025-11-25T13:43:06.000Z thumbnail image

Stay in the know with updates to Nivolumab in Refractory Biliary Tract Cancers Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nivolumab in Refractory Biliary Tract Cancers Clinical Trial page.